Key result
Single-dose oral estrogen improves isovolumic relaxation time by ~15% in postmenopausal diastolic dysfunction.
Why the study?
The acute effects of a single dose of oral estrogen on left ventricular diastolic function in hypertensive postmenopausal women with diastolic dysfunction were unclear.
Does a single dose of oral conjugated estrogen improve left ventricular diastolic function in hypertensive postmenopausal women with diastolic dysfunction?
RCT (n=60)
Double-blind
Randomized
Does a single dose of oral conjugated estrogen improve left ventricular diastolic function in hypertensive postmenopausal women with diastolic dysfunction?
A single oral dose of conjugated estrogen acutely improves echocardiographic markers of diastolic relaxation in hypertensive postmenopausal women with diastolic dysfunction.
Answers are grounded in this paper and cite their sources.
Acute estrogen may improve diastolic parameters in select hypertensive postmenopausal women; leaves open whether chronic use affects outcomes or warrants practice change.
This double-blind, placebo-controlled crossover study examined the acute effects of a single dose of oral estrogen on left ventricular (LV) diastolic function in 30 hypertensive postmenopausal women who had diastolic dysfunction as well, documented by Doppler electrocardiography. Thirty normotensive women served as a control group. The study group had a diastolic blood pressure exceeding 90 mm Hg, impaired diastolic LV filling, and a normal or increased LV mass index on two-dimensional echocardiography. Patients were randomly assigned to receive a single 0.625-mg oral dose of conjugated estrogen (Premarin) or placebo, with a washout period of at least 48 hours between treatments. Antihypertensive treatment was continued during the study. Echocardiography was repeated 3 hours after treatment and 2 to 3 hours after the last meal. Estrogen therapy did not significantly alter heart rate or blood pressure. Estrogen administration did not significantly alter any Doppler parameters or the ratio between maximum early and late diastolic flow velocities in normotensive women. This ratio tended to normalize in hypertensive women, and the isovolumic relaxation time improved significantly after estrogen from 124 to 105 msec (P ≤ .005 compared with placebo). It seems that hypertensive postmenopausal women may realize improved diastolic filling from a single dose of estrogen. This effect may have special clinical importance given the prominent role of diastolic dysfunction in chronic heart failure. Fertil Steril 2000;73:66–71
No takes yet. Share an insight, caveat, or question.
Fak et al. (2000) conducted an RCT in Hypertension with diastolic dysfunction in postmenopausal women (n=60). Conjugated estrogen (Premarin) vs. Placebo was evaluated on Isovolumic relaxation time (LV diastolic function) (p=≤.005). A single dose of oral estrogen improved isovolumic relaxation time from 124 to 105 msec in hypertensive postmenopausal women with diastolic dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: